Zuolin Li

Dr. Zuolin Li

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 November 2023 in Cellular and Molecular Life Sciences
Verified
Journal Article
Closed access
PDF file
JJJia-Ling Ji
Jia-Ling Ji
JLJun-Ying Li
Jun-Ying Li
JLJian-Xiang Liang
Jian-Xiang Liang
YZYan Zhou
Yan Zhou
CLCong-Cong Liu
Cong-Cong Liu
ZLZuolin Li
Zuolin Li


23 August 2024 in Kidney International Reports
Verified
Journal Article
Open access
CLCong-Cong Liu
Cong-Cong Liu
JJJia-Ling Ji
Jia-Ling Ji
ZWZe Wang
Ze Wang
XZXing-Jian Zhang
Xing-Jian Zhang
LDLin Ding
Lin Ding
RMRui-Xia Ma
Rui-Xia Ma
Renal tubulointerstitial inflammation represents an effective indicator for predicting the progression of diabetic kidney disease (DKD). Mitophagy abnormality is 1 of the most important factors involved in tubule injury. However, the exact molecular mechanism underlying mitophagy abnormality-mediated tubulointerstitial inflammation in DKD remains poorly understood. In this study, a streptozotocin-induced DKD mouse model was established and HK-2 cells treated with high glucose (HG) served as an in vitro model. Tubular mitophagy was regulated through pharmacological urolithin A (UA) administration. The functional effect of the transient receptor potential cation channel, subfamily C, member 6 (TRPC6) was explored using genetic interventions in vivo and in vitro. We found that renal tubulointerstitial inflammation in DKD was closely associated with mitophagy inhibition, which was mediated by disturbance of PINK1/Parkin pathway. Mitophagy activation significantly attenuated tubular injury and tubulointerstitial inflammation. Further, it was found that TRPC6 was markedly increased in DKD and played an essential role in mitophagy inhibition by activating calpain-1. Knockdown of Trpc6 partially reversed mitophagy abnormality and consequently attenuated tubular injury and tubulointerstitial inflammation in vivo and in vitro. Finally, we found that tubular TRPC6-mediated mitophagy inhibition was blocked with BAPTA (a specific Ca2+ chelator) or calpeptin (a specific calpain-1 inhibitor). Our study reveals that TRPC6-calpain-1 axis promotes tubulointerstitial inflammation in DKD by inhibiting mitophagy.

28 November 2024 in Cellular Signalling
Verified
Journal Article
Closed access
YZYao Zhang
Yao Zhang
JZJin-Hua Zhu
Jin-Hua Zhu
YZYan Zhou
Yan Zhou
ZLZhong-Tang Li
Zhong-Tang Li
HLHong Liu
Hong Liu
ZLZuolin Li
Zuolin Li

27 March 2023 in Molecular and Cellular Endocrinology
Verified
Journal Article
Closed access
LDLin Ding
Lin Ding
ZLZuolin Li
Zuolin Li
YZYan Zhou
Yan Zhou
NLNan-Chi Liu
Nan-Chi Liu
SLShan-Shan Liu
Shan-Shan Liu
RMRui-Xia Ma
Rui-Xia Ma

26 January 2025 in Renal Failure
Verified
Journal Article
Open access
DYDan-Dan Yao
Dan-Dan Yao
XYXiao-Wei Yan
Xiao-Wei Yan
YZYan Zhou
Yan Zhou
ZLZuolin Li
Zuolin Li
FQFang-Xin Qiu
Fang-Xin Qiu
Vascular calcification is common and progressive in patients with chronic kidney disease. However, the risk factors associated with the progression of vascular calcification in patients receiving maintenance dialysis have not been fully elucidated. Here, we aimed to evaluate vascular calcification and identify the factors associated with its progression in patients receiving maintenance hemodialysis. This is a prospective longitudinal study that included 374 patients receiving maintenance hemodialysis. The participants received assessments of coronary artery calcification (CAC) and abdominal aortic calcification (AAC), as measured by computed tomography. After the baseline investigation, a 2 years follow-up was performed. We also detected the markers of endothelial injury [E-selectin and soluble intercellular adhesion molecule-1 (sICAM-1)]. Finally, the risk factors affecting the CAC and AAC progression were examined by multivariate logistic regression analysis. Among 374 patients, the median [interquartile range (IQR)] age was 54.0 (40.0-62.0) years; 59.9% of patients were male. The median (IQR) follow-up time was 1.9 (1.8-2.0) years for all patients. By the end of 2-year follow-up, progression of vascular calcification (including CAC and AAC) was observed in 58.0% of patients. Further, compared with the patients without progression of vascular calcification, the endothelial injury (including E-selectin and sICAM-1) of patients with progression of vascular calcification was markedly enhanced. Moreover, after adjustment for the confounders, endothelial injury was a risk factor for the progression of vascular calcification. The present study indicated that endothelial injury is one of the risk factors for the progression of vascular calcification in patients receiving maintenance hemodialysis.